Midwest Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.9M Buy
68,243
+3,104
+5% +$3.17M 0.93% 27
2026
Q1
$59.9M Buy
65,139
+1,518
+2% +$1.54M 0.75% 38
2025
Q4
$68.4M Buy
63,621
+13,464
+27% +$12.9M 0.85% 26
2025
Q3
$38.3M Buy
50,157
+920
+2% +$685K 0.5% 51
2025
Q2
$38.4M Buy
+49,237
New +$38.3M 0.53% 47

Other funds holding LLY

Midwest Trust's LLY Position: Q2 2026 in Review

Midwest Trust increased its Eli Lilly (LLY) stake by 4.8% in Q2 2026, buying an estimated $3.17M and bringing the position to 68,243 shares worth $81.9M. The position accounts for 0.93% of the portfolio, ranked #27.

Midwest Trust first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Midwest Trust held 68,243 shares of Eli Lilly worth $81.9M as of Q2 2026.
  • Midwest Trust bought 3,104 Eli Lilly shares in Q2 2026, an estimated $3.17M.
  • Eli Lilly made up 0.93% of Midwest Trust's portfolio in Q2 2026, its #27 holding.
  • Midwest Trust first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.